We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
GeneDx Holdings
WGS
$2.3B
| $610K | ﹤0.01% |
21,056
-8,011
| -28% | -$367K |
|
2877
Ramaco Resources Class A
METC
$649M
| $609K | ﹤0.01% |
68,415
-250
| -0.4% | -$2.58K |
|
2878
Holley
HLLY
$384M
| $608K | ﹤0.01% |
150,024
+1,198
| +0.8% | +$8.96K |
|
2879
Fossil Group
FOSL
$318M
| $605K | ﹤0.01% |
177,137
+3,878
| +2% | +$19.9K |
|
|
CRGE
2880
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $605K | ﹤0.01% |
343,690
+28,850
| +9% | +$82.3K |
|
2881
Atomera
ATOM
$212M
| $603K | ﹤0.01% |
59,492
-187
| -0.3% | -$2.21K |
|
|
BBIG
2882
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $603K | ﹤0.01% |
32,349
+3,072
| +10% | +$61.2K |
|
2883
BayCom
BCML
$333M
| $602K | ﹤0.01% |
34,247
-143
| -0.4% | -$2.76K |
|
|
ZYXI
2884
DELISTED
Zynex
ZYXI
| $601K | ﹤0.01% |
66,196
-2,005
| -3% | -$17.5K |
|
2885
NextDecade
NEXT
$1.78B
| $597K | ﹤0.01% |
99,157
| – | – |
|
2886
Open Text
OTEX
$6.04B
| $597K | ﹤0.01% |
22,586
| – | – |
|
|
MKFG
2887
DELISTED
Markforged Holding Corporation
MKFG
| $597K | ﹤0.01% |
30,187
+640
| +2% | +$14.8K |
|
|
OMIC
2888
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $597K | ﹤0.01% |
7,962
+189
| +2% | +$19.7K |
|
2889
Tango Therapeutics
TNGX
$4.41B
| $591K | ﹤0.01% |
163,200
-134
| -0.1% | -$572 |
|
2890
NACCO Industries
NC
$320M
| $586K | ﹤0.01% |
12,468
| – | – |
|
2891
United States Lime & Minerals
USLM
$3.44B
| $584K | ﹤0.01% |
28,595
-1,030
| -3% | -$21.9K |
|
|
APPH
2892
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $584K | ﹤0.01% |
296,770
+3,098
| +1% | +$10K |
|
|
DZSI
2893
DELISTED
DZS Inc. Common Stock
DZSI
| $583K | ﹤0.01% |
51,581
-1,052
| -2% | -$14.9K |
|
2894
Information Services Group
III
$248M
| $582K | ﹤0.01% |
122,354
+1,467
| +1% | +$9.12K |
|
|
JBIO
2895
Jade Biosciences
JBIO
$1.34B
| $580K | ﹤0.01% |
999
-109
| -10% | -$72.8K |
|
2896
Third Coast Bancshares
TCBX
$738M
| $580K | ﹤0.01% |
33,853
-943
| -3% | -$18.4K |
|
2897
Willdan Group
WLDN
$1.3B
| $578K | ﹤0.01% |
39,047
-330
| -0.8% | -$7.89K |
|
2898
Sight Sciences
SGHT
$412M
| $577K | ﹤0.01% |
90,713
-1,219
| -1% | -$10.3K |
|
2899
Latham Group
SWIM
$880M
| $576K | ﹤0.01% |
160,447
-5,195
| -3% | -$29.6K |
|
2900
Village Super Market
VLGEA
$639M
| $575K | ﹤0.01% |
29,747
-35
| -0.1% | -$772 |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.